Ömer An
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
-
- RNA Research and Splicing
- RNA modifications and cancer
- RNA regulation and disease
- RNA and protein synthesis mechanisms
- Genomics and Chromatin Dynamics
- Bioinformatics and Genomic Networks
- CRISPR and Genetic Engineering
Papers in
-
- RNA Research and Splicing 12
- RNA regulation and disease 11
- RNA modifications and cancer 8
- CRISPR and Genetic Engineering 5
- RNA and protein synthesis mechanisms 4
- Protein Degradation and Inhibitors 3
- Bioinformatics and Genomic Networks 3
-
- Cancer Genomics and Diagnostics 4
- Co-authors
- Henry Yang (21 shared papers)Francesca D. Ciccarelli (3 shared papers)Leilei Chen (11 shared papers)Yangyang Song (10 shared papers)Thanos P. Mourikis (1 shared paper)Giovanni Marco Dall’Olio (1 shared paper)Daryl Jin Tai Tay (9 shared papers)Vanessa Hui En Ng (9 shared papers)
- Journals
- Blood (3 papers)Nature Communications (3 papers)Nucleic Acids Research (3 papers)Stem Cell Research & Therapy (2 papers)iScience (1 paper)
- Partner nations
- SingaporeUnited KingdomUnited States
In The Last Decade
Ömer An
29 papers receiving 735 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 210
- Molecular Biology 628
- Hematology 61
- Immunology 55
- Oncology 61
Countries citing papers authored by Ömer An
This map shows the geographic impact of Ömer An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ömer An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ömer An more than expected).
Fields of papers citing papers by Ömer An
This network shows the impact of papers produced by Ömer An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ömer An. The network helps show where Ömer An may publish in the future.
Co-authors
The 25 scholars most cited alongside Ömer An, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 80 | |
| 2 | 2020 | 78 | |
| 3 | 2015 | 77 | |
| 4 | 2019 | 54 | |
| 5 | 2022 | 50 | |
| 6 | 2014 | 46 | |
| 7 | 2020 | 44 | |
| 8 | 2018 | 42 | |
| 9 | 2018 | 38 | |
| 10 | 2020 | 32 | |
| 11 | 2019 | 31 | |
| 12 | 2019 | 28 | |
| 13 | 2013 | 22 | |
| 14 | 2022 | 21 | |
| 15 | 2020 | 19 | |
| 16 | 2022 | 15 | |
| 17 | Database update NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes | 2014 | 15 |
| 18 | 2021 | 13 | |
| 19 | 2024 | 9 | |
| 20 | 2023 | 4 |
About Ömer An
Ömer An is a scholar working on Molecular Biology, Cancer Research, Genetics, Genetics and Hematology, having authored 30 papers that have together received 740 indexed citations. Recurring topics across this work include RNA Research and Splicing (12 papers), RNA regulation and disease (11 papers), RNA modifications and cancer (8 papers), CRISPR and Genetic Engineering (5 papers), Cancer Genomics and Diagnostics (4 papers), RNA and protein synthesis mechanisms (4 papers), Protein Degradation and Inhibitors (3 papers) and Bioinformatics and Genomic Networks (3 papers). The work is most often cited by research in Cancer Research (210 citations), Molecular Biology (628 citations), Hematology (61 citations), Immunology (55 citations) and Oncology (61 citations). Ömer An has collaborated with scholars based in Singapore, United Kingdom and United States. Frequent co-authors include Henry Yang, Francesca D. Ciccarelli, Leilei Chen, Yangyang Song, Thanos P. Mourikis, Giovanni Marco Dall’Olio, Daryl Jin Tai Tay, Vanessa Hui En Ng, Sze Jing Tang and Jian Han. Their work appears in journals such as Blood, Nature Communications, Nucleic Acids Research, Stem Cell Research & Therapy and iScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.